foxo4 dri senolytic FOXO4-DRI: The Peptide That Targets Zombie Cells and Aging – Revolution Health & Wellness Molecular targets of senolytic drugs.
Molecular targets of senolytic drugs. Download Scientific Diagram The FOXO4 peptide in a DRI conformation (D amino acids in a retro reversed sequence), henceforth named FOXO4 DRI, competes with FOXO4 for p53 binding in a dose dependent manner and doing so with higher affinity. FOXO4 DRI 10mg Senolytic Research Peptide Kalyx Labs The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications
Pay in 4 interest-free payments of $7.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 18 - Sep 23

